The Chinese American Society of Nuclear Medicine (CASNM) held its annual meeting on June 11, 2013 at the Floata Seafood Restaurant when about 100 participants gathered in Vancouver at the time of the SNM annual meeting. The Chinese Society of Nuclear Medicine (CSNM) also brought its delegation to join the dinner party.
CASNM was established in 1977 as a nonpro?t, nonpolitical organization with the objectives of encouraging professional contact among members all over the world, facilitating scienti?c exchanges in research and development, and promoting young scholars as well as international interaction with regard to the science of nuclear medicine and molecular imaging with a special focus in the Chinese community. The membership of CASNM is not restricted to practitioners living in North America. We also welcome participants from Europe, Australia, Asia, and elsewhere to join our organization. The current president of CASNM is Xiao-Feng Li, MD, PhD, University of Louisville, and secretary/treasurer is Hancheng Cai, Ph.D., Wayne State University.
The CASNM Lifetime Achievement award 2013 was presented to Dr. Hank F. Kung, from the University of Pennsylvania. He was also the recipient of the prestigious Paul C. Aebersold Award (2004) and Kuhl-Lassen Award (2013) from the SNM. Hank is most well-known for the development of FDA approved amyloid imaging agent florbetapir 18F AV-45.
Dr. Hank F. Kung (middle) received the Lifetime Achievement award from Dr. Xiao-Feng Li (left, current president) and Dr. Xiaoyuan (Shawn) Chen (right, president-elect).
CASNM Koon Yan (Chris) Pak Young scientist awards went to Mr. Zhibo Liu from the University of British-Columbia (“Kit” 18F-radiolabeling based on B-F bond formation), Dr. Min Zhou from the MD Anderson Cancer Center (Radioactive [64Cu]CuS nanoparticles and near-infrared laser irradiation for combined radiotherapy and phothothermal therapy: in-vivo feasibility study in animal models), and Dr. Zhenhua Hu from the Chinese Academy of Sciences (Endoscopic Cerenkov luminescence imaging of nude mice with gastric tumors). Dr. Zhen Cheng from Stanford University also highlighted the achievements of physicians and scientists of Chinese origin in the last year.
During the past year, the CASNM has taken several steps toward strengthening the organization and expanding its activities. The relationship between CASNM and CSNM is also growing; Dr. Yongxue Zhang introduced the development of CSNM and its attendees. Dr. Rui An, on behalf of CSNM, introduced the First Global Conference of Chinese Professionals in Nuclear Medicine and Molecular Imaging (1st GCCPNMMI, November 1-3, 2013, Xiamen, China), which is co-sponsored by CSNM, CASNM and other nuclear medicine and molecular imaging associations. This conference expects to be one of the largest nuclear medicine and molecular imaging meetings for Chinese professionals, bringing together a great number of physicians, physics, researchers, scientists and experts with the highest academic standards in the field.
CASNM 2014 annual meeting will be held in conjunction with the 61th annual meeting of the SNMMI in St. Louis, MO. For anyone who is interested in learning more about CASNM, please visit the CASNM Web site at www.casnmmi.org.
Xiaoyuan Chen, PhD
National Institutes of Health
Xiao-Feng Li, MD, PhD
University of Louisvill